NASDAQ$ADUS

Addus HomeCare Corporation · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Addus HomeCare's Q4 2021 earnings were announced, revealing a 14.6% increase in revenues to $224.6 million and a 54.6% increase in net income to $13.1 million.

Addus HomeCare Corporation reported a strong fourth quarter in 2021, with revenues reaching $224.6 million, a 14.6% increase year-over-year. Net income increased by 54.6% to $13.1 million, and adjusted earnings per diluted share rose by 18.3% to $0.97. The company's personal care service line saw an 8.0% increase on a same-store basis.

  • Net service revenues increased by 14.6% to $224.6 million compared to Q4 2020.
  • Net income increased by 54.6% to $13.1 million, with earnings per diluted share at $0.81.
  • Adjusted EBITDA increased by 27.5% to $26.7 million.
  • Personal care same-store revenue increased by 8.0%, exceeding the target range of 3-5%.

Headline financials

Total Revenue

$225M

Previous: $196M+14.6%
EPS (adj)

$0.97

Previous: $0.82+18.3%
Hospice organic growth

1.3%

No prior period
Capital Expenditures

$1.43M

Previous: $938K+52.6%
Free Cash Flow

$23.8M

Previous: $35.2M-32.4%
Net Income

$13.1M

Previous: $8.4M+55.5%
Operating Income

$19.4M

Previous: $11.7M+65.2%
Gross Profit

$72.8M

Previous: $59.1M+23.2%
Cash & Equivalents

$169M

Previous: $145M+16.4%
Total Assets

$948M

Previous: $893M+6.2%
Stock-Based Comp

$2.33M

Previous: $2.02M+15.4%

Revenue & EPS history

Addus · Revenue · Quarterly

$225M

Q4 2021+14.6%vs Q4 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Addus · $225M total across 3 segments · Q4 2021

  • Personal Care
    $175M+6.5%
  • Hospice
    $40.2M+45.6%
  • Home Health
    $9.38M+132.2%

Forward guidance

Addus HomeCare anticipates continued growth in demand for home-based care and is well-capitalized to pursue acquisition opportunities that meet their strategic criteria in 2022.

Tailwinds

  • Expects continued growth in demand for home-based care.
  • Well-capitalized to pursue acquisition opportunities.
  • Believes the pandemic has raised awareness about the value of safe, quality, home-based care.
  • Extending market reach to deliver greater value to shareholders.
  • Acquisition of JourneyCare and Summit Home Health expands services in Illinois.

Headwinds

  • Ongoing COVID-19 challenges.
  • Labor challenges.
  • Uncertainty regarding the outcome of discussions with managed care organizations.
  • Changes in reimbursement and government regulations.
  • Potential impacts to business operations due to the COVID-19 global pandemic.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+1.2%

Avg return

Earnings day

+2.3%

Avg return

5 days after

+5.0%

Avg return

30 days after

58%

37 / 64 earnings

Positive

+23.7%

Q4 2019

Best reaction

-19.6%

Q4 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.7%-0.6%-10.6%
Q4 2025-9.1%-12.0%-17.0%
Q3 2025-5.9%-5.0%-4.1%
Q1 2025+4.1%+6.3%+7.5%
Q4 2024-10.4%-12.0%-10.1%
Q3 2024-1.7%+1.0%-2.1%
Q2 2024+3.5%+3.6%+8.5%
Q1 2024+6.5%+11.3%+16.8%
Q4 2023+3.4%+5.3%+16.4%
Q3 2023-3.7%+3.3%+7.0%
Q2 2023+1.2%+3.9%-0.1%
Q1 2023+5.8%+0.3%+10.3%
Q4 2022+3.9%+2.5%-0.4%
Q3 2022+3.1%+3.8%+4.8%
Q2 2022+3.1%+0.6%-3.9%
Q1 2022-2.3%-4.7%-4.2%
Q4 2021+20.5%+20.4%+15.8%
Q3 2021-0.5%+9.1%-8.9%
Q2 2021+9.1%+5.3%+4.0%
Q1 2021-6.6%-8.1%-10.0%
Q4 2020-11.3%-14.2%-11.3%
Q3 2020+11.9%+10.3%+4.6%
Q2 2020+2.7%-4.6%-7.1%
Q1 2020+10.2%+2.7%+22.5%
Q4 2019+23.7%+8.5%+42.1%
Q3 2019-0.9%-0.1%+8.6%
Q2 2019+1.4%+4.4%-0.2%
Q1 2019+3.6%+3.0%+8.8%
Q4 2018-2.8%-7.8%-3.8%
Q3 2018+6.5%+10.8%+16.7%
Q2 2018-4.4%-7.1%-3.4%
Q1 2018+3.1%+1.8%+11.9%
Q4 2017-0.3%+8.6%+38.5%
Q3 2017-1.4%-5.8%-7.8%
Q2 2017-0.3%-1.4%-1.3%
Q1 2017+11.3%+9.4%+2.6%
Q4 2016+1.2%+0.1%-7.5%
Q3 2016+17.4%+28.7%+32.7%
Q2 2016+13.8%+8.6%+27.1%
Q1 2016-1.1%
Q4 2015-16.6%
Q3 2015-12.7%
Q2 2015+4.4%
Q1 2015-3.4%
Q4 2014+3.7%
Q3 2014+7.1%
Q2 2014+1.3%
Q1 2014+1.8%
Q4 2013-19.6%
Q3 2013+4.3%
Q2 2013+9.3%
Q1 2013+0.9%
Q4 2012+13.2%
Q3 2012+10.5%
Q2 2012+1.1%
Q1 2011-0.0%
Q1 2012-7.8%
Q4 2011+6.6%
Q3 2010-1.3%
Q3 2011-1.3%
Q2 2011-17.3%
Q2 2010-17.3%
Q4 2010+0.2%
Q1 2010+2.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro